Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis

Katsuyuki Iida1, Ken Itoh, Yoshito Kumagai

  • 1Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Cancer Research
|September 18, 2004
PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) is crucial for detoxifying carcinogens like N-nitrosobutyl(4-hydroxybutyl)amine (BBN). The chemopreventive agent oltipraz enhances this detoxification, protecting against BBN-induced bladder cancer in mice.

Area of Science:

  • Biochemistry
  • Toxicology
  • Cancer Prevention

Background:

  • Phase 2 detoxifying enzymes, like UDP-glucuronosyltransferases (UGTs), protect against carcinogens.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates the expression of these detoxifying enzymes.
  • Oltipraz is a synthetic agent known to induce phase 2 enzymes.

Purpose of the Study:

  • To investigate the role of Nrf2 in susceptibility to the urinary bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine (BBN).
  • To evaluate the chemopreventive efficacy of oltipraz in Nrf2-deficient mice exposed to BBN.

Main Methods:

  • Utilized Nrf2-deficient (Nrf2-/-) and wild-type (WT) mice.
  • Administered BBN to induce urinary bladder carcinoma.
  • Assessed the chemopreventive effects of oltipraz on BBN-induced carcinogenesis and detoxification pathways.

Main Results:

  • Nrf2-/- mice exhibited significantly higher incidence of urinary bladder carcinoma following BBN exposure compared to WT mice.
  • Oltipraz induced BBN-detoxifying phase 2 enzymes in a Nrf2-dependent manner.
  • Oltipraz reduced BBN-induced bladder cancer in WT mice but not in Nrf2-/- mice, by enhancing BBN glucuronidation and counteracting UGT1A suppression.

Conclusions:

  • Nrf2 and its downstream genes are essential for the detoxification of BBN.
  • Oltipraz exerts chemopreventive effects against BBN-induced carcinogenesis by enhancing carcinogen detoxification in an Nrf2-dependent manner.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...